The Living Guidelines: UA/NSTEMI Recomendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy Suggest Revisions to the CLASS III Guidelines

Click on the edit button above to make suggested revisions to the guidelines.


 * CLASS III

Intravenous fibrinolytic therapy is not indicated in patients without acute ST-segment elevation, a true posterior MI, or a presumed new left bundle-branch block. (Level of Evidence: A)